Mitochondrial complex I activity in microglia sustains neuroinflammation

Mitochondrial complex I activity in microglia sustains neuroinflammation

13 March 2024 | L. Peruzzotti-Jametti, C. M. Willis, G. Krzak, R. Hamel, L. Pirvan, R. B. Ionescu, J. A. Reisz, H. A. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. M. Casey, A. M. R. van den Bosch, A. M. Niceaie, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takats, J. C. Marioni, A. D'Alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
The study investigates the role of mitochondrial complex I (CI) activity in microglia and its impact on neuroinflammation in chronic neurological diseases, particularly multiple sclerosis (MS). Using a multiomics approach, including single-cell RNA sequencing (scRNA-seq) and liquid chromatography–mass spectrometry (LC–MS), the researchers identified a molecular signature that sustains microglial activation through CI-driven reverse electron transport and reactive oxygen species (ROS) production. Mechanistically, blocking CI in pro-inflammatory microglia protects the central nervous system from neurotoxic damage and improves functional outcomes in an animal model of MS-like disease. The findings suggest that targeting CI activity in myeloid cells could be a potential therapeutic strategy to foster neuroprotection in chronic inflammatory disorders of the central nervous system. The study also highlights the importance of CI in maintaining a balanced state of microglial activation and preventing oxidative stress and neurotoxicity.The study investigates the role of mitochondrial complex I (CI) activity in microglia and its impact on neuroinflammation in chronic neurological diseases, particularly multiple sclerosis (MS). Using a multiomics approach, including single-cell RNA sequencing (scRNA-seq) and liquid chromatography–mass spectrometry (LC–MS), the researchers identified a molecular signature that sustains microglial activation through CI-driven reverse electron transport and reactive oxygen species (ROS) production. Mechanistically, blocking CI in pro-inflammatory microglia protects the central nervous system from neurotoxic damage and improves functional outcomes in an animal model of MS-like disease. The findings suggest that targeting CI activity in myeloid cells could be a potential therapeutic strategy to foster neuroprotection in chronic inflammatory disorders of the central nervous system. The study also highlights the importance of CI in maintaining a balanced state of microglial activation and preventing oxidative stress and neurotoxicity.
Reach us at info@study.space
[slides and audio] Mitochondrial complex I activity in microglia sustains neuroinflammation